Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan.

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

"AcknowledgementThis work was supported in part by Takeda Science Foundation (Visionary Research Grant), Tokyo-Hokenkai Byotai-Seiri Laboratory (Clinical Research Grant), and the Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University (2021–11).The author is thankful to Tomoaki Ishikawa and Tsutomu Hashimoto, LSI Medience Corporation, Sendai, Japan, and Manabu Obara and Naoki Kajiyama, QIAGEN, Tokyo, Japan for providing technical advice and support throughout the project."